Estrella Immunopharma, Inc. (ESLAW) KPIs and segments
ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.03 (-28.82%)
Close on Nov 17, 2026Market cap $14.42MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Estrella Immunopharma's business
Coming soon
This tab will track the numbers specific to Estrella Immunopharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?